BFBI39 Stock Chart & Stats
$58.24
$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range$44.08 - $66.99
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
R$631.90M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.07
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding10,850,002
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BFBI39 FAQ
What was First Trust NYSE Arca Biotechnology Index Fund Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh’s price range in the past 12 months?
First Trust NYSE Arca Biotechnology Index Fund Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh lowest stock price was $44.08 and its highest was $66.99 in the past 12 months.
What is First Trust NYSE Arca Biotechnology Index Fund Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh’s market cap?
First Trust NYSE Arca Biotechnology Index Fund Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh’s market cap is R$631.90M.
When is First Trust NYSE Arca Biotechnology Index Fund Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were First Trust NYSE Arca Biotechnology Index Fund Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh’s earnings last quarter?
Currently, no data Available
Is First Trust NYSE Arca Biotechnology Index Fund Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh overvalued?
According to Wall Street analysts First Trust NYSE Arca Biotechnology Index Fund Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh’s price is currently Undervalued.
Does First Trust NYSE Arca Biotechnology Index Fund Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh pay dividends?
First Trust NYSE Arca Biotechnology Index Fund Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh does not currently pay dividends.
What is First Trust NYSE Arca Biotechnology Index Fund Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh’s EPS estimate?
First Trust NYSE Arca Biotechnology Index Fund Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does First Trust NYSE Arca Biotechnology Index Fund Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh have?
First Trust NYSE Arca Biotechnology Index Fund Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh has 10,850,002 shares outstanding.
What happened to First Trust NYSE Arca Biotechnology Index Fund Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of First Trust NYSE Arca Biotechnology Index Fund Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh?
Currently, no hedge funds are holding shares in BR:BFBI39
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Global X Telemedicine & Digital Health ETF Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh
―
iShares Genomics Immunology and Healthcare ETF Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh
―
iShares US Pharmaceuticals ETF Shs Unsponsored Brazilian Depositary Receipt Repr 0.05555555 Sh
―
iShares US Medical Devices ETF Shs Unsponsored Brazilian Depositary Receipt Repr 0.0285714 Sh
―
Biomm SA
―